Bronchoscopes Market Size is USD 933 Million in 2025

The global bronchoscopes market size was valued at USD 873 million in 2024, is projected to reach approximately USD 1,701 million by 2034. Driven by the rising prevalence of respiratory disorders. The bronchoscopes market is expanding at a lucrative pace due to the rising prevalence of respiratory diseases such as chronic obstructive pulmonary disease (COPD), lung cancer, asthma, and pneumonia. For instance, data from the World Health Organization indicates that COPD is the fourth leading cause of death globally, accounting for 3.5 million deaths in 2021.

Bronchoscopes Market Statical Scope

What Is a Bronchoscope?

A bronchoscope is a thin, lighted tube used by professionals for examining the lungs and airways. Rising air pollution and increasing smoking among individuals are two major factors contributing to these respiratory disorders. The rise of these devices has significantly simplified the overall diagnostic process by eliminating long hospital stays and reducing the need for complex traditional procedures.

The use of bronchoscopes has increased rapidly in recent years, but there are still some concerning factors that may hamper the growth of this endoscopy equipment market. One key issue is the risk of cross-contamination in reusable tubes, which may transmit infections or cause significant harm to other individuals. Moreover, some developing regions still lack skilled professionals, which may also limit efficiency and usage in these areas. Additionally, the lack of awareness regarding health insurance systems in these regions may affect the adoption rate of such healthcare solutions.

What Drives the Market for Bronchoscopes?

The bronchoscopes market is expected to gain major traction in the future as companies adopt single-use solutions to prevent infections while also providing a cost-effective option for healthcare settings in the long run. The increasing use of these devices with endobronchial ultrasound (EBUS) is expected to play a major role in improving diagnostic accuracy for physicians. Endoscopy equipment is anticipated to gain more momentum in the coming years as the healthcare sector witnesses a growing number of pulmonary care units. Additionally, several emerging countries in the Middle East and Africa, Asia Pacific, and Latin America are expected to act as game-changers in these regions, as they continue to enhance their healthcare infrastructure through technological adoption.

What Is the Impact of AI in the Bronchoscopes Market?

The bronchoscopes market is also expected to gain significant momentum due to technological advancements, with artificial intelligence (AI) and machine learning (ML) influencing growth through improvements in patient outcomes. For instance, the use of AI-powered imaging is playing a crucial role in detecting early-stage conditions such as mucosal abnormalities, lung lesions, and other related disorders. The advantage of using these technologies is their ability to analyze patients’ historical data, giving healthcare providers an upper hand in making accurate and timely decisions.

Bronchoscopes Market Share, By Region, 2024 (%)

• North America – Holds 35% of the market, supported by advanced healthcare systems and high medical spending in the U.S. and Canada. Dominates due to robust healthcare infrastructure and strong adoption of medical products in hospitals and outpatient facilities.
• Europe – Represents 30% of the market, driven by healthcare regulations and the need for medical products across various care settings. Gaining momentum as the region focuses on patient safety and efficient healthcare solutions.
• Asia Pacific – Accounts for 25% of the market, with growing healthcare infrastructure and rising patient numbers. Gaining momentum due to increased healthcare spending and expanding medical technology adoption.
• LAMEA – Holds 10% of the market, with emerging healthcare markets in Latin America, the Middle East, and Africa. Not dominating due to slower adoption of advanced medical products but showing growth with rising healthcare demands and infrastructure improvements.

Bronchoscopes Market Share, By Product, 2024 (%)

• Rigid – Holds 30% of the market, representing a durable and sturdy product type commonly used for long-term use. Not dominating due to higher adoption of more flexible and disposable options in healthcare.
• Flexible – Accounts for 50% of the market, favored for its versatility and comfort in various medical applications. Dominates due to its widespread use across both hospitals and outpatient facilities, offering a balance of durability and ease of use.
• Disposable – Represents 20% of the market, typically used for single-use applications to prevent contamination and ensure patient safety. Not dominating due to the higher preference for reusable, flexible solutions, but still significant in certain medical sectors.

Bronchoscopes Market Share, By End Use, 2024 (%)

• Hospitals – Holds 60% of the market, driven by high demand for medical products in inpatient care. Dominates due to the larger volume of patients and the need for versatile and durable medical devices.
• Outpatient Facilities – Accounts for 40% of the market, where medical products are used for short-term procedures and diagnostics. Gaining momentum as outpatient care becomes more common for routine and specialized treatments.

Bronchoscopes Market Companies

• Olympus Corporation
• Ambu A/S
• Teleflex Incorporated.
• KARL STORZ SE & Co. KG
• FUJIFILM Holdings Corporation
• Boston Scientific Corporation
• Richard Wolf GmbH
• Pentax Medical (HOYA Corporation)
• Cook Medical
• Broncus Medical, Inc.

Bronchoscopes Market Segmentation

By Type

• Rigid
• Flexible
• Disposable

By Application

• Hospitals
• Outpatient Facilities

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa